- Home
- CELC vs IAC Comparison
CELC vs IAC Comparison
Compare CELC & IAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- IAC
- Stock Information
- Founded
- CELC 2011
- IAC N/A
- Country
- CELC United States
- IAC United States
- Employees
- CELC N/A
- IAC N/A
- Industry
- CELC Medical Specialities
- IAC Computer Software: Programming Data Processing
- Sector
- CELC Health Care
- IAC Technology
- Exchange
- CELC Nasdaq
- IAC Nasdaq
- Market Cap
- CELC 3.1B
- IAC 2.7B
- IPO Year
- CELC 2017
- IAC 1992
- Fundamental
- Price
- CELC $74.11
- IAC $33.46
- Analyst Decision
- CELC Strong Buy
- IAC Strong Buy
- Analyst Count
- CELC 5
- IAC 14
- Target Price
- CELC $69.40
- IAC $48.21
- AVG Volume (30 Days)
- CELC 1.4M
- IAC 1.3M
- Earning Date
- CELC 11-12-2025
- IAC 11-03-2025
- Dividend Yield
- CELC N/A
- IAC N/A
- EPS Growth
- CELC N/A
- IAC N/A
- EPS
- CELC N/A
- IAC N/A
- Revenue
- CELC N/A
- IAC $3,653,760,000.00
- Revenue This Year
- CELC N/A
- IAC N/A
- Revenue Next Year
- CELC N/A
- IAC $0.08
- P/E Ratio
- CELC N/A
- IAC N/A
- Revenue Growth
- CELC N/A
- IAC 23.49
- 52 Week Low
- CELC $7.58
- IAC $29.56
- 52 Week High
- CELC $83.00
- IAC $45.25
- Technical
- Relative Strength Index (RSI)
- CELC 64.02
- IAC 51.45
- Support Level
- CELC $71.06
- IAC $29.56
- Resistance Level
- CELC $79.97
- IAC $32.61
- Average True Range (ATR)
- CELC 5.13
- IAC 0.98
- MACD
- CELC 0.11
- IAC 0.11
- Stochastic Oscillator
- CELC 53.43
- IAC 82.75
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About IAC IAC Inc.
IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.